Impact of Annexin A3 expression in gastric cancer cells

Neoplasma

Volumn 61, Issue 3, 2014, Pages 257-264

  Yu, S Y ^a   Li, Y ^a   Fan, L Q ^a   Zhao, Q ^a   Tan, B B ^a   Liu, Y ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Annexin A3; Gastric cancer; Migration; Proliferation; SiRNA

Indexed keywords

CYCLIN D1; GELATINASE A; GLYCEROPHOSPHOINOSITOL INOSITOLPHOSPHODIESTERASE; INTERSTITIAL COLLAGENASE;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MIDDLE AGED; MTT ASSAY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; STOMACH CANCER; WESTERN BLOTTING;

ANNEXIN A3; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HUMANS; MALE; NEOPLASM INVASIVENESS; RNA, SMALL INTERFERING; STOMACH NEOPLASMS;

EID: 84902334355     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2014_033     Document Type: Article

References (37)

1. PARKIN DM, BRAY F, FERLAY J, PISANI P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108. http://dx.doi.org/10.3322/canjclin.55.2.74
2. ROUKOS DH. Genome-wide association studies and aggressive surgery toward individualized prevention, and improved local control and overall survival for gastric cancer. Ann Surg Oncol 2009; 16: 795-798. http://dx.doi.org/10.1245/s10434-009-0317-8
3. WU K, NIE Y, GUO C, CHEN Y, DING J, et al. Molecular basis of therapeutic approaches to gastric cancer. J Gastroenterol Hepatol 2009; 24: 37-41. http://dx.doi.org/10.1111/j.1440-1746.2008.05753.x
4. LEUNG WK, WU MS, KAKUGAWA Y, KIM JJ, YEOH KG, et al. Asia Pacific Working Group on Gastric Cancer.Screen-ing for gastric cancer in Asia: current evidence and practice. Lancet Oncol 2008; 9: 279-287. http://dx.doi.org/10.1016/S1470-2045(08)70072-X
5. GRAVALOS C, JIMENO A. HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Ann Oncol 2008; 19: 1523-1529. http://dx.doi.org/10.1093/annonc/mdn169
6. D'Ugo D, Rausei S, Biondi A, Persiani R. Preoperative treatment and surgery in gastric cancer: friends or foes? Lancet Oncol 2009; 10: 191-195. http://dx.doi.org/10.1016/S1470-2045(09)70021-X
7. CUNNINGHAM D, ALLUM WH, STENNING SP, THOMPSON JN, VAN DE VELDE CJ, et al. Perioperative chemotherapy versus surgery alone for resectable gastro-esophageal cancer. N Engl J Med 2006; 355: 11-20. http://dx.doi.org/10.1056/NEJMoa055531
8. MACDONALD JS, SMALLEY SR, BENEDETTI J, Hun-Dahl SA, ESTES NC, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001; 345: 725-730. http://dx.doi.org/10.1056/NEJMoa010187
9. JEMAL A, BRAY F, Center MM, FERLAY J, WARD E, et al. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90. http://dx.doi.org/10.3322/caac.20107
10. BI S, LIU JR, LI Y, WANG Q, LIU HK, et al. Gamma-Toeot-rienol modulates the paracrine secretion of VEGF induced by cobalt () chloride via ERK signaling pathway in gastric adenocarcinoma SGC-7901 cell line. Toxicology 2010; 274: 27-33. http://dx.doi.org/10.1016/j.tox.2010.05.002
11. FU X, WANG Q, CHEN J, HUANG X, CHEN X, et al. Clinical significance of miR-221 and its inverse correlation with p27Kip in hepatocellular carcinoma. Mol Biol Rep 2011; 38: 3029-3035. http://dx.doi.org/10.1007/s11033-010-9969-5
12. WU N, LIU S, GUO C, HOU Z, SUN MZ. Te roleofannexin A3 playing in cancers. Clin Transl Oncol 2013; 15: 106-110. http://dx.doi.org/10.1007/s12094-012-0928-6
13. BAINE MJ, CHAKRABORTY S, SMITH LM, MALLYA K, SASSON AR, et al. Transcriptional profiling of peripheral blood mononuclear cells in pancreatic cancer patients identifies novel genes with potential diagnostic utility. PLoS One 2011; 6: e17014. http://dx.doi.org/10.1371/journal. pone.0017014
14. BIANCHI C, BOMBELLI S, RAIMONDO F, TORSELLO B, ANGELONI V, et al. Primary cell cultures from human renal cortex and renal-cell carcinoma evidence a differential expression of two spliced isoforms of Annexin A3. Am J Pathol 2010; 176: 1660-1670. http://dx.doi.org/10.2353/ajpath.2010.090402
15. JUNG EJ, MOON HG, PARK ST, CHO BI, LEE SM, et al. Decreased annexin A3 expression correlates with tumor progression in papillary thyroid cancer. Proteomics Clin Appl 2010; 4: 528-537.
16. YAN X, YIN J, YAO H, MAO N, YANG Y, et al. Increased expression of annexin A3 is a mechanism of platinum resistance in ovarian cancer. Cancer Res 2010; 70: 1616-1624. http://dx.doi.org/10.1158/0008-5472.CAN-09-3215
17. SHEKOUH AR, THOMPSON CC, PRIME W, CAMPBELL F, HAMLETT J, et al. Application of laser capture microdis-section combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma. Proteomics 2003; 3: 1988-2001. http://dx.doi.org/10.1002/pmic.200300466
18. LIU YF, XIAO ZQ, LI MX, LI MY, ZHANG PF, et al. Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma. J Pathol 2009; 217: 54-64. http://dx.doi.org/10.1002/path.2429
19. TONG SW, YANG YX, HU HD, AN X, YE F, et al. Proteomic investigation of 5-fluorouracil resistance in a human hepatocel-lular carcinoma cell line. J Cell Biochem 2012; 113: 1671-1680.
20. NIIMI S, HARASHIMA M, GAMOU M, HYUGA M, SEKI T, et al. Expression of Annexin A3 in Primary Cultured Pa-renchymal Rat Hepatocytes and Inhibition of DNA Synthesis by Suppression of Annexin A3 Expression Using RNA Interference. Biol Pharm Bull 2005; 28: 424-428. http://dx.doi.org/10.1248/bpb.28.424
21. KAMANGAR F, DORES GM, ANDERSON WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographicregionsofthe world. JClin Oncol 2006; 24: 2137-2150. http://dx.doi.org/10.1200/JCO.2005.05.2308
22. MOSS SE, MORGAN RO. Te annexins. Genome Biol 2004; 5: 219. http://dx.doi.org/10.1186/gb-2004-5-4-219
23. MUSSUNOOR S, MURRAY GI. Te role of annexins in tumour development and progression. J Pathol 2008; 216: 131-140. http://dx.doi.org/10.1002/path.2400
24. HAYES MJ, MOSS SE. Annexins and disease. Biochem Biophys Res Commun 2004; 322: 1166-1170. http://dx.doi.org/10.1016/j.bbrc.2004.07.124
25. BIAOXUE R, XILING J, SHUANYING Y, WEI Z, XIGUANG C, et al. Upregulation of Hsp90-beta and annexin A1 correlates with poor survival and lymphatic metastasis in lung cancer patients. J Exp Clin Cancer Res 2012; 31: 70. http://dx.doi.org/10.1186/1756-9966-31-70
26. JUNG EJ, MOON HG, PARK ST, CHO BI, LEE SM, et al. Decreased annexin A3 expression correlates with tumor progression in papillary thyroid cancer. Proteomics Clin Appl 2010; 4: 528-537.
27. Li X, Chen L, LIANG XJ, GAO YF, WANG XJ, et al. Annexin A5 protein expression is associated with the histological differentiation of uterine cervical squamous cell carcinoma in patients with an increased serum concentration. Mol Med Report 2012; 6: 1249-1254.
28. WATANABE T, ITO Y, SATO A, HOSONO T, NIIMI S, et al. Annexin A3 as a negative regulator of adipocyte differentiation. J Biochem 2012; 152: 355-363. http://dx.doi.org/10.1093/jb/mvs084
29. HANNON GJ. RNA interference. Nature 2002; 418: 244-251. http://dx.doi.org/10.1038/418244a
30. Lin LL, Huang HC, JUAN HF. Revealing the molecular mechanism of gastric cancer marker annexin a4 in cancer cell proliferation using exon arrays. PLoS One 2012; 7: e44615. http://dx.doi.org/10.1371/journal.pone.0044615
31. KHAU T, LANGENBACH SY, SCHULIGA M, HARRIS T, JOHNSTONE CN, et al. Annexin-1 signals mitogen-stimu-lated breast tumor cell proliferation by activation of the formyl peptide receptors (FPRs) 1 and 2. FASEB J 2011; 25: 483-496. http://dx.doi.org/10.1096/f.09-154096
32. ABBAS T, DUTTA A. P21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 2009; 9: 400-414. http://dx.doi.org/10.1038/nrc2657
33. LI N, ZHONG X, LIN X, GUO J, ZOU L, et al. Lin-28 homologue A (LIN28A) promotes cell cycle progression via regulation of cyclin-dependent kinase 2 (CDK2), cyclin D1 (CCND1), and cell division cycle 25 homolog A (CDC25A) expression in cancer. J Biol Chem 2012; 287: 17386-17397. http://dx.doi.org/10.1074/jbc.M111.321158
34. BROUSTAS CG, ZHU A, LIEBERMAN HB. Rad9 Contributes to Prostate Tumor Progression by Promoting Cell Migration and Anoikis Resistance. J Biol Chem 2012; 287: 41324-41333. http://dx.doi.org/10.1074/jbc.M112.402784
35. CHATTERJEE BE, YONA S, ROSIGNOLI G, YOUNG RE, NOURSHARGH S, et al. Annexin 1-deficient neutrophils exhibit enhanced transmigration in vivo and increased responsiveness in vitro. J Leukoc Biol 2005; 78: 639-646. http://dx.doi.org/10.1189/jlb.0405206
36. WU CY, TANEYHILL LA. Annexin a6 modulates chick cranial neural crest cell emigration. PLoS One 2012; 7: e44903. http://dx.doi.org/10.1371/journal.pone.0044903
37. ZHAI H, ACHARYA S, GRAVANIS I, MEHMOOD S, Sei-Dman RJ, et al. Annexin A2 promotes glioma cell invasion and tumor progression. J Neurosci 2011; 31: 14346-14360. http://dx.doi.org/10.1523/JNEUROSCI.3299-11.2011